Biological Assembly 1  

 3D View: Structure | Ligand Interaction

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Monomer - A1 

Biological assembly 1 assigned by authors.

Macromolecule Content

• Total Structure Weight: 34.70 kDa 
• Atom Count: 2029 
• Modelled Residue Count: 251 
• Deposited Residue Count: 297 
• Unique protein chains: 1

1MUO

CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE

• DOI: 10.2210/pdb1MUO/pdb

• Classification: TRANSFERASE
• Organism(s): Homo sapiens
• Mutation(s): No 


• Deposited: 2002-09-24 Released: 2003-04-15 
• Deposition Author(s): Cheetham, G.M.T., Knegtel, R.M.A., Coll, J.T., Renwick, S.B., Swenson, L., Weber, P., Lippke, J.A., Austen, D.A.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 2.90 Å
• R-Value Free: 0.290 
• R-Value Work: 0.240 
• R-Value Observed: 0.260 

Literature

Crystal Structure of Aurora-2, an Oncogenic Serine/Threonine Kinase

Cheetham, G.M.T., Knegtel, R.M.A., Coll, J.T., Renwick, S.B., Swenson, L., Weber, P., Lippke, J.A., Austen, D.A.

(2002) J Biol Chem 277: 42419-42422

• PubMed: 12237287 
• DOI: 10.1074/jbc.C200426200
• Primary Citation of Related Structures:  
  1MUO


• PubMed Abstract: 
  

Aurora-2 is a key member of a closely related subgroup of serine/threonine kinases that plays important roles in the completion of essential mitotic events. Aurora-2 is oncogenic and amplified in various human cancers and could be an important therapeutic target for inhibitory molecules that would disrupt the cell cycle and block proliferation. We report the first crystal structure of Aurora-2 kinase in complex with adenosine. Analysis of residues in the active site suggests differences with structurally and biologically related protein kinases. The activation loop, which contains residues specific to the Aurora family of kinases, has a unique conformation. These results provide valuable insight into the design of selective and highly potent ATP-competitive inhibitors of the Aurora kinases.

---

Organizational Affiliation: 

Vertex Pharmaceuticals (Europe) Ltd., 88 Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom. [e-mail]

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Aurora-related kinase 1	A	297	Homo sapiens	Mutation(s): 0  Gene Names: AURKA, AIK, AIRK1, ARK1, AURA, AYK1, BTAK, IAK1, STK15, STK6 EC: 2.7.11.1
Find proteins for O14965 (Homo sapiens) Explore O14965  Go to UniProtKB:  O14965
NIH Common Fund Data Resources
PHAROS:  O14965 GTEx:  ENSG00000087586

Small Molecules

Ligands 1 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram
ADN	A	ADENOSINE C10 H13 N5 O4 OIRDTQYFTABQOQ-KQYNXXCUSA-N

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 2.90 Å
• R-Value Free: 0.290 
• R-Value Work: 0.240 
• R-Value Observed: 0.260 
• Space Group: P 3₂ 2 1

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 86.2	α = 90
b = 86.2	β = 90
c = 75.4	γ = 120

Software Package:

Software Name	Purpose
MOSFLM	data reduction
SCALA	data scaling
CNS	refinement
CCP4	data scaling
CNS	phasing

Structure Validation

Entry History 

Deposition Data

• Deposited Date: 2002-09-24 
• Released Date: 2003-04-15 
Deposition Author(s): Cheetham, G.M.T., Knegtel, R.M.A., Coll, J.T., Renwick, S.B., Swenson, L., Weber, P., Lippke, J.A., Austen, D.A.

Revision History  

• Version 1.0: 2003-04-15
  Type: Initial release
  
• Version 1.1: 2008-04-28
  Changes: Version format compliance
• Version 1.2: 2011-07-13
  Changes: Version format compliance